Abstracts - faqs.org

Abstracts

Retail industry

Search abstracts:
Abstracts » Retail industry

When your baby starts crying, don't reach for that teaspoon

Article Abstract:

Liquid paracetamol preparations can be very useful in reducing the severity of symptoms in a child who is clearly unwell. However, many parents give their child these preparations too frequently, simply because the child seems miserable or difficult. Research indicates that using liquid paracetamol in this way can cause more health problems than it solves. Children can begin to suffer recurrent headaches, which parents automatically treat with yet more liquid paracetamol. Children who suffer headaches should not be treated with a painkiller on more than two days a week at most.

Author: Howard, Nigel
Publisher: Financial Times Ltd.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 1997
Nonnarcotic Analgesic Preparations, Children, Child health, Analgesics

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Corn Flakes could save your life

Article Abstract:

It is now recognized that folic acid, a B vitamin, can reduce the blood level of homocysteine, high levels of which are linked with a raised risk of heart disease. According to pathologist Dr Kilmer McCully, adults should aim for a total daily folic acid intake of between 350 mg and 400 mg. It is hard to obtain this much from food, as natural folic acid does not survive cooking or digestion very well. For this reason, folic acid is most easily obtained from vitamin supplements and vitamin-enriched foods, such as Corn Flakes.

Author: Baker, Peter
Publisher: Financial Times Ltd.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 1998
Vitamin Preparations, Vitamins, Homocysteine, Folic acid deficiency

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


EUROPE: REMINYL APPROVED

Article Abstract:

Reminyl, a drug designed to help treat patients suffering from Alzheimer's disease, has been given approval in 13 European countries. Reminyl is the result of co-operation between Shire Pharmaceuticals and Johnson & Johnson.

Publisher: Financial Times Ltd.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
Government regulation (cont), European Union, Central Nervous System Prep, Pharmaceutical industry, Central nervous system agents, Johnson & Johnson, Shire Pharmaceuticals Group PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects
Similar abstracts:
  • Abstracts: Let's keep our eyes on the Swedes. We're crying too much over spilt oil. Big is no longer beautiful
  • Abstracts: Death in the forest. Heat is on for desert haven. Once upon a time in the West
  • Abstracts: In markets, the worst rarely happens. But don't count on it. Pictures worth taking
  • Abstracts: The truth about pinhole glasses. All done for the love of logos. UK: CONTACT LENS PATENT WORTH [pound]6MN
  • Abstracts: Drink advertising 'inspires young to start taking drugs' UK: NEW PUBLIC TRANSPORT TARGETS UNVEILED. UK: GOVERNMENT CRACKDOWN ON DRINK DRIVING
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.